[Federal Register Volume 89, Number 196 (Wednesday, October 9, 2024)]
[Notices]
[Pages 81922-81923]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23322]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; SCORCH (Single Cell Opioid Responses in the Context 
of HIV) Program: Data Coordination, Analysis, and Scientific 
Outreach; Data Mining and Functional Validation.
    Date: November 15, 2024.
    Time: 10:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, National Institute on 
Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Caitlin Elizabeth Angela Moyer, Ph.D., 
Scientific Review Officer, Scientific Review Branch, National 
Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 
6021, Bethesda, MD 20892, (301) 443-4577, <a href="/cdn-cgi/l/email-protection#8cefede5f8e0e5e2a2e1e3f5e9fecce2e5e4a2ebe3fa"><span class="__cf_email__" data-cfemail="c0a3a1a9b4aca9aeeeadafb9a5b280aea9a8eea7afb6">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Ending the Epidemic: New Models of Integrated HIV/
AIDS, Addiction, and Primary Care Services.
    Date: November 15, 2024.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, National Institute on 
Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Trinh T. Tran, Ph.D., Scientific Review Officer, 
Scientific Review Branch, Office of Extramural Policy, National 
Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 
6021, Bethesda, MD 20892, (301) 827-5843, <a href="/cdn-cgi/l/email-protection#94e0e6fdfafcbae0e6f5fad4fafdfcbaf3fbe2"><span class="__cf_email__" data-cfemail="86f2f4efe8eea8f2f4e7e8c6e8efeea8e1e9f0">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIH Support for Conferences and Scientific Meetings.
    Date: November 19, 2024.
    Time: 1:30 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, National Institute on 
Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Li Rebekah Feng, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Office of Extramural Policy, 
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, 
MSC 6021, Bethesda, MD 20892, (301) 827-7245, <a href="/cdn-cgi/l/email-protection#483a2d2a2d232920662e2d262f08262120662f273e"><span class="__cf_email__" data-cfemail="bbc9ded9ded0dad395ddded5dcfbd5d2d395dcd4cd">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Cutting-Edge Basic Research Awards (CEBRA).
    Date: November 21, 2024.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, National Institute on 
Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Sheila Pirooznia, Ph.D., Scientific Review 
Officer, Division of Extramural Review, Scientific Review Branch, 
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, 
MSC 6021, Bethesda, MD 20892, (301) 496-9350, 
<a href="/cdn-cgi/l/email-protection#42312a272b2e236c322b302d2d382c2b23022c2b2a6c252d34"><span class="__cf_email__" data-cfemail="0b78636e62676a257b627964647165626a4b656263256c647d">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse, Special 
Emphasis Panel; NIDA Avant-Garde Program for HIV and Substance Use 
Disorder Research; NIDA Avenir Award Program for HIV and Substance 
Use Disorder Research.
    Date: December 9, 2024.
    Time: 9:30 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, National Institute on 
Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Sheila Pirooznia, Ph.D., Scientific Review 
Officer, Division of Extramural Review, Scientific Review Branch, 
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, 
MSC 6021, Bethesda, MD 20892, (301) 496-9350, 
<a href="/cdn-cgi/l/email-protection#b1c2d9d4d8ddd09fc1d8c3dedecbdfd8d0f1dfd8d99fd6dec7"><span class="__cf_email__" data-cfemail="cbb8a3aea2a7aae5bba2b9a4a4b1a5a2aa8ba5a2a3e5aca4bd">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA Avant-Garde Program for HIV and Substance Use 
Disorder Research; NIDA Avenir Award Program for HIV and Substance 
Use Disorder Research.
    Date: December 12, 2024.
    Time: 9:30 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, National Institute on 
Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Sheila Pirooznia, Ph.D., Scientific Review 
Officer, Division of Extramural Review, Scientific Review Branch, 
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, 
MSC 6021, Bethesda, MD 20892, (301) 496-9350, 
<a href="/cdn-cgi/l/email-protection#84f7ece1ede8e5aaf4edf6ebebfeeaede5c4eaedecaae3ebf2"><span class="__cf_email__" data-cfemail="44372c212d28256a342d362b2b3e2a2d25042a2d2c6a232b32">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research

[[Page 81923]]

Training; 93.279, Drug Abuse and Addiction Research Programs, 
National Institutes of Health, HHS)

    Dated: October 3, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-23322 Filed 10-8-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>